However, IL-10 production was higher in CD14+ cells from advanced-stage HCC patients (212.9 ± 146.9 pg/mL) than in those from early-stage patients (64.5 ± 49.6 pg/mL). This evidence concerns the gene CD14 and hepatocellular carcinoma.